Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky.
Publication
, Journal Article
Aringer, M; Steiner, G; Graninger, W; Smolen, J
Published in: Arthritis Rheum
July 2001
Duke Scholars
Published In
Arthritis Rheum
DOI
ISSN
0004-3591
Publication Date
July 2001
Volume
44
Issue
7
Start / End Page
1721 / 1722
Location
United States
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Lupus Erythematosus, Systemic
- Humans
- Arthritis & Rheumatology
- Animals
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Aringer, M., Steiner, G., Graninger, W., & Smolen, J. (2001). Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky. Arthritis Rheum, 44(7), 1721–1722. https://doi.org/10.1002/1529-0131(200107)44:7<1721::AID-ART302>3.0.CO;2-J
Aringer, M., G. Steiner, W. Graninger, and J. Smolen. “Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky.” Arthritis Rheum 44, no. 7 (July 2001): 1721–22. https://doi.org/10.1002/1529-0131(200107)44:7<1721::AID-ART302>3.0.CO;2-J.
Aringer M, Steiner G, Graninger W, Smolen J. Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky. Arthritis Rheum. 2001 Jul;44(7):1721–2.
Aringer, M., et al. “Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky.” Arthritis Rheum, vol. 44, no. 7, July 2001, pp. 1721–22. Pubmed, doi:10.1002/1529-0131(200107)44:7<1721::AID-ART302>3.0.CO;2-J.
Aringer M, Steiner G, Graninger W, Smolen J. Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky. Arthritis Rheum. 2001 Jul;44(7):1721–1722.
Published In
Arthritis Rheum
DOI
ISSN
0004-3591
Publication Date
July 2001
Volume
44
Issue
7
Start / End Page
1721 / 1722
Location
United States
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Lupus Erythematosus, Systemic
- Humans
- Arthritis & Rheumatology
- Animals
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences